Oncobiologics, Inc. 4
4 · Oncobiologics, Inc. · Filed Dec 22, 2016
Insider Transaction Report
Form 4
Bahrt Kenneth
Chief Medical Officer
Transactions
- Award
Common Stock
2016-12-21+50,000→ 80,985 total
Footnotes (2)
- [F1]This security represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The shares underlying this restricted stock unit award vests in two equal installments on each of December 21, 2017 and December 21, 2018, in each case subject to the Reporting Person's continuous service to the Issuer through each such date. In addition, 100% of the shares underlying the restricted stock unit award will satisfy the time-based vesting restrictions upon the occurrence of a change of control, subject to continued service through such event.